financetom
Business
financetom
/
Business
/
Boeing Shares Are Trading Higher Tuesday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing Shares Are Trading Higher Tuesday: What's Going On?
Sep 23, 2025 8:07 AM

Boeing Company ( BA ) shares are trading higher Tuesday after Uzbekistan Airways agreed to purchase up to 22 Boeing 787 Dreamliners and reports indicated Turkey may order Boeing ( BA ) aircraft.

What To Know: Uzbekistan Airways signed a deal for 14 787-9 airplanes, with an option to buy up to eight more, in a transaction valued at $8.5 billion. The agreement is expected to support about 35,000 U.S. jobs, according to the Commerce Department.

“With its fuel efficiency and operational flexibility, the 787 Dreamliner will help Uzbekistan Airways expand into new markets, connecting more travelers to their rich culture,” said Brad McMullen, Boeing ( BA ) senior vice president of commercial sales and marketing.

Separately, Bloomberg reported that Turkish President Tayyip Erdogan is preparing a major purchase of hundreds of Boeing ( BA ) planes and Lockheed Martin jets.

Erdogan aims to offset the planned payments with more than $10 billion in local production agreements. The deals, which are pending approval, are expected to be discussed during Erdogan's Sept. 25 White House meeting with President Donald Trump.

Trump said the meeting will also cover a potential F-16 deal and ongoing F-35 discussions with Turkey.

Related Link: Trump’s Controversial Tariffs Generate Nearly $350 Billion, Becoming ‘Very Significant’ US Revenue Source, Says Economist

BA Price Action: At the time of publication, Boeing ( BA ) shares are trading 2.57% higher at $217.46, according to data from Benzinga Pro.

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Grifols Subsidiary Biotest Expects $1 Billion in US Sales Over Seven Years From Yimmugo Intravenous
Grifols Subsidiary Biotest Expects $1 Billion in US Sales Over Seven Years From Yimmugo Intravenous
Jul 1, 2024
08:26 AM EDT, 07/01/2024 (MT Newswires) -- Grifols ( GRFS ) said Monday its Biotest subsidiary forecasts about $1 billion in revenue over the next seven years from US sales of its intravenous immunoglobulin Yimmugo, after recent US Food and Drug Administration approval as a treatment for primary antibody deficiency syndromes. The drug will launch in Q1 in the US....
Neurocrine Biosciences Says US FDA Accepts NDAs With Priority Review for Adrenal Gland Disease Drug
Neurocrine Biosciences Says US FDA Accepts NDAs With Priority Review for Adrenal Gland Disease Drug
Jul 1, 2024
08:22 AM EDT, 07/01/2024 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Monday that the US Food and Drug Administration has accepted two New Drug Applications with Priority review designations for for crinecerfont, to treat children, adolescents, and adults with classic congenital adrenal hyperplasia. The company said the submitted applications for crinecerfont include a capsule formulation and an oral...
Vera Therapeutics Appoints David Johnson as Chief Operating Officer
Vera Therapeutics Appoints David Johnson as Chief Operating Officer
Jul 1, 2024
08:24 AM EDT, 07/01/2024 (MT Newswires) -- Vera Therapeutics ( VERA ) said Monday it appointed David Johnson as Chief Operating Officer, effective immediately. Before joining Vera, Johnson served as the Chief Commercial Officer at Global Blood Therapeutics until it was acquired by Pfizer ( PFE ) in 2022, the company said. ...
Ryan Specialty's Board Approves Leadership Succession Plan
Ryan Specialty's Board Approves Leadership Succession Plan
Jul 1, 2024
08:16 AM EDT, 07/01/2024 (MT Newswires) -- Ryan Specialty Group Holdings (RYAN) said Monday that its board of directors has unanimously approved a leadership succession plan to be implemented on Oct. 1. Under the plan, Chairman and Chief Executive Officer, Patrick G. Ryan, will transition to the role of executive chairman, and Chairman and CEO of Ryan Turner Specialty, Timothy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved